Cargando…

Efficacy of bromocriptine on glycemic and metabolic control of prediabetic patients

BACKGROUND: It is suggested that bromocriptine could be effective in treatment of prediabetic patients and, consequently, in preventing type 2 diabetes (T2DM). In this study, we investigated the effectiveness of bromocriptine on glycemic and metabolic control of prediabetic patients. MATERIALS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khalilzade, Saied Hossein, Aminorroaya, Ashraf, Hovsepain, Silva, Amini, Masoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746945/ https://www.ncbi.nlm.nih.gov/pubmed/26918235 http://dx.doi.org/10.4103/2277-9175.170678

Ejemplares similares

Different metabolic/obesity phenotypes are differentially associated with development of prediabetes in adults: Results from a 14-year cohort study
por: Haghighatdoost, Fahimeh, et al.
Publicado: (2019)

Effect of metformin on thyroid stimulating hormone and thyroid volume in patients with prediabetes: A randomized placebo-controlled clinical trial
por: Karimifar, Mozhgan, et al.
Publicado: (2014)

Prevalence and predictors of prediabetes and its coexistence with high blood pressure in first-degree relatives of patients with type 2 diabetes: A 9-year cohort study
por: Hadi Alijanvand, Moluk, et al.
Publicado: (2020)

Effect of oral magnesium supplement on cardiometabolic markers in people with prediabetes: a double blind randomized controlled clinical trial
por: Salehidoost, Rezvan, et al.
Publicado: (2022)

Severity of the metabolic syndrome as a predictor of prediabetes and type 2 diabetes in first degree relatives of type 2 diabetic patients: A 15-year prospective cohort study
por: Meamar, Rokhsareh, et al.
Publicado: (2020)

Patterns of changes in serum lipid profiles in prediabetic subjects: results from a 16-year prospective cohort study among first-degree relatives of type 2 diabetic patients
por: Safari, Shahla, et al.
Publicado: (2020)

A 16-year prospective cohort study to evaluate effects of long-term fluctuations in obesity indices of prediabetics on the incidence of future diabetes
por: Safari, Shahla, et al.
Publicado: (2021)

The effect of alendronate on lipid profile of postmenopausal women with osteopenia and prediabetes: A randomized triple-blind clinical trial
por: Karimifard, Maryam, et al.
Publicado: (2021)

The effect of hydroxychloroquine on glucose control and insulin resistance in the prediabetes condition
por: Sheikhbahaie, Fahimeh, et al.
Publicado: (2016)

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
por: Via, Michael A, et al.
Publicado: (2010)

The effects of probiotic and synbiotic supplementation on metabolic syndrome indices in adults at risk of type 2 diabetes: study protocol for a randomized controlled trial
por: Kassaian, Nazila, et al.
Publicado: (2017)

Effect of bromocriptine on glycemic control, risk of cardiovascular diseases and weight in patients with type 2 diabetes: a systematic review
por: Birhan, Mulualem Tesfaye, et al.
Publicado: (2023)

Evaluation of the efficacy and safety of bromocriptine QR in type 2 diabetes
por: Ramteke, Karuna Balwant, et al.
Publicado: (2011)

Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes?
por: Salehidoost, Rezvan, et al.
Publicado: (2012)

The association of exposure to air pollution with changes in plasma glucose indices, and incidence of diabetes and prediabetes: A prospective cohort of first-degree relatives of patients with type 2 diabetes
por: Feizi, Awat, et al.
Publicado: (2023)

Hypertension in Non-Type 2 Diabetes in Isfahan, Iran: Incidence and Risk Factors
por: Janghorbani, Mohsen, et al.
Publicado: (2017)

The prevalence of hypogonadism in diabetic men in Isfahan Endocrine and Metabolism Research Center, Isfahan, Iran
por: Mirzaei, Mohammad Reza, et al.
Publicado: (2012)

Evaluating the efficacy of Salsalate on prediabetic and diabetic patients with fatty liver: A randomized clinical trial
por: Faghihimani, Elham, et al.
Publicado: (2013)

The Effect of Levothyroxine and Selenium versus Levothyroxine Alone on Reducing the Level of Anti-thyroid Peroxidase Antibody in Autoimmune Hypothyroid Patients
por: Kachouei, Ali, et al.
Publicado: (2018)

Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.
por: Missale, C., et al.
Publicado: (1995)

Evaluation of Peripheral Arterial Disease in Prediabetes
por: Faghihimani, Elham, et al.
Publicado: (2014)

Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension
por: Janghorbani, Mohsen, et al.
Publicado: (2017)

Cross-sectional and longitudinal assessments of risk factors associated with hypertension and moderately increased albuminuria comorbidity in patients with type 2 diabetes: a 9-year open cohort study
por: Hadi Alijanvand, Moluk, et al.
Publicado: (2019)

Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple‐blind clinical trial
por: Karimi Fard, Maryam, et al.
Publicado: (2018)

The Effect of Glycemic Status on Kidney Stone Disease in Patients with Prediabetes
por: Lien, Tzu-Hsien, et al.
Publicado: (2016)

Prevalence of Goitre in Isfahan, Iran, Fifteen Years After Initiation of Universal Salt Iodization
por: Ashraf, Aminorroaya, et al.
Publicado: (2010)

Prediction of response to bromocriptine in acromegaly.
por: Atkinson, A. B., et al.
Publicado: (1978)

Repurposing of Bromocriptine for Cancer Therapy
por: Seo, Ean-Jeong, et al.
Publicado: (2018)

Central Hyperthermia Treated with Bromocriptine
por: Natteru, P., et al.
Publicado: (2017)

Iodine repletion, thyrotoxicosis and atrial fibrillation in Isfahan, Iran
por: Aminorroaya, Ashraf, et al.
Publicado: (2004)

Efficacy and safety of HIMABERB® Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial
por: Panigrahi, Antarmayee, et al.
Publicado: (2023)

Effects of tolcapone and bromocriptine on cognitive stability and flexibility
por: Cameron, Ian G. M., et al.
Publicado: (2018)

Bromocriptine mesylate: Food and Drug Administration approved new approach in therapy of non-insulin dependant diabetes mellitus with poor glycemic control
por: Keche, Yogendra
Publicado: (2010)

Effects of Vitamin D deficiency treatment on metabolic markers in Hashimoto thyroiditis patients
por: Anaraki, Parichehr Vahabi, et al.
Publicado: (2017)

Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction
por: Haghikia, Arash, et al.
Publicado: (2018)

Patterns and Predictors of Long-Term Glycemic Control in Patients with Type 2 Diabetes
por: Janghorbani, Mohsen, et al.
Publicado: (2012)

Prevalence of Vitamin D Deficiency among Adult Population of Isfahan City, Iran
por: Hovsepian, Silva, et al.
Publicado: (2011)

Effect of Bromocriptine-QR (a Quick-Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects
por: Gaziano, J. Michael, et al.
Publicado: (2012)

Bromocriptine, a clinical and pharmacological review /
por: Thorner, Michael O.
Publicado: (1980)

Bromocriptine in type 2 diabetes mellitus
por: Shivaprasad, C., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3th3mss1j9s61fl3pgfrqt247d